Phase 2 studies of CCX168 for treatment of anca-vasculitis IND120784, OD14-4320

Ended Cooperative Agreement Awarded Last action

Award ID
R01FD005414
Recipient
Awarding agency
Obligated
$500,000

Award facts

Assistance listing
93.103 Food and Drug Administration Research
Completion date
Place of performance
Mountain View, CA 94043, USA

Award details come from USAspending.gov.

Quick answers

Who received award R01FD005414?

R01FD005414 was awarded to Chemocentryx, Inc. by Food and Drug Administration (Department of Health and Human Services) on May 1, 2016.

How much is award R01FD005414 worth?

$500,000 has been obligated on R01FD005414.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award